Author

N. M. Parrish

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. Kaushik· 2 shared E. Nuermberger· 2 shared B. N. Kreiswirth· 1 shared G. Lamichhane· 1 shared J. Lee· 1 shared N. Ammerman· 1 shared N. C. Ammerman· 1 shared O. Martins· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Kaushik

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

New β-Lactamase Inhibitors Nacubactam and Zidebactam Improve the In Vitro Activity of β-Lactam Antibiotics Against Mycobacterium abscessus Complex Clinical Isolates

A. Kaushik, N. Ammerman, N. M. Parrish, E. Nuermberger

bioRxiv · Apr 4, 2019Microbiology

In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates

A. Kaushik, N. C. Ammerman, J. Lee, O. Martins, B. N. Kreiswirth, G. Lamichhane, N. M. Parrish, E. Nuermberger

This study evaluates the in vitro activity of β-lactamase inhibitors relebactam and vaborbactam with β-lactams against MABC clinical isolates, showing improved anti-MABC activity.

bioRxiv · Dec 19, 2018Microbiology